Copyright
©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 112675
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112675
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112675
Figure 1 Clinical pathway for the integrated management of early hepatocellular carcinoma screening.
AFP: Alpha-fetoprotein; DCP: Des-gamma-carboxy prothrombin; AFP-L3: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein; ctDNA: Circulating tumor DNA; CTCs: Circulating tumor cells; miRNAs: MicroRNAs; CT: Computed tomography; MRI: Magnetic resonance imaging; HCC: Hepatocellular carcinoma.
- Citation: Liu ZH, Wang WJ, Dang SS. Early screening for liver cancer must be performed. World J Hepatol 2025; 17(11): 112675
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/112675.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.112675
